Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Operating Expenses | 2,110 | 2,260 | 11,498 | 9,409 | 1,029 |
| Operating Income | -2,110 | -2,260 | -11,498 | -9,409 | -1,029 |
| Interest Expense | 0 | 0 | -1 | 0 | 104 |
| Other Income | 0 | 0 | 0 | 0 | -2,296 |
| Pre-tax Income | -2,110 | -2,260 | -11,497 | -9,409 | -3,429 |
| Net Income Continuous | -2,110 | -2,260 | -11,497 | -9,409 | -3,429 |
| Net Income | $-2,110 | $-2,260 | $-11,497 | $-9,409 | $-3,429 |
| EPS Basic Total Ops | -0.09 | -0.11 | 2.66 | -0.66 | -4.19 |
| EPS Basic Continuous Ops | -0.09 | -0.11 | 3.53 | -0.66 | -4.19 |
| EPS Diluted Total Ops | -0.09 | -0.11 | 2.66 | -0.66 | -4.19 |
| EPS Diluted Continuous Ops | -0.09 | -0.11 | 3.53 | -0.66 | -4.19 |
| EBITDA(a) | $-2,109 | $-2,243 | $-11,941 | $-8,962 | $-1,028 |